Re: Camillo Porta, Emiliano Calvo, Miguel A. Climent, et al. Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial. Eur Urol 2012;61:826-33

Eur Urol. 2012 Jul;62(1):e5-6; author reply e7-8. doi: 10.1016/j.eururo.2012.03.048. Epub 2012 Apr 7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Molecular Targeted Therapy*
  • Protein Kinase Inhibitors / therapeutic use*
  • Sirolimus / analogs & derivatives*
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • TOR Serine-Threonine Kinases
  • Sirolimus